Novel NIR-Ⅱ-Activated titanate-supported iridium nanoplatform delivers multimodal antitumor therapy synergistic with PD-1 inhibition in TNBC
Peixin Du(Sichuan University), Jing Jing(Sichuan University), Meixu Chen(Sichuan University), Jing Yu(Sichuan University), Hubing Shi(Sichuan University), Zihan Xu(Sichuan University), Tianyue Xu(Jilin Agricultural University), Xian Jiang(Sichuan University), Ting Sun(Sichuan University), Yujie Zhao(Sichuan University), Linlin Song(Sichuan University), Zhu Huang(Shanghai Jiao Tong University)
Cited by 4
Related Papers
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance
|Nature Communications|2012|620
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
|Cancer Cell|2023|330
Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth
|Nature Communications|2015|221